DOI QR코드

DOI QR Code

Development and Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Detecting Adrenocortical Hormones and Establishment of Age-Stratified Reference Intervals in Reproductive-Aged Women from Guangxi, China

  • Yixuan Liu (Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University) ;
  • Tingwei Jin (Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University) ;
  • Yushuang Wei (Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University) ;
  • Xuelian Qin (Guangxi Precision Medicine Industrial Technology Institute) ;
  • Siyu Deng (Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University) ;
  • Jie Zheng (Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University) ;
  • Boteng Yan (Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University) ;
  • Yuanyuan Nong (Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University) ;
  • Yu Ye (Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University) ;
  • Shengzhu Huang (Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University) ;
  • Yu Long (Department of Obstetrics, The First Affiliated Hospital of Guangxi Medical University) ;
  • Jianmin Li (Department of Hospital Office, The Second Nanning People's Hospital) ;
  • Ganqin Wang (Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University) ;
  • Pei Huan (Eugenics and Genetics Department, Reproductive Hospital of Guangxi Zhuang  Autonomous Region) ;
  • Jinghang Jiang (The Reproductive Medicine Center, Jingmen People's Hospital) ;
  • Fan Wu (Guangxi Precision Medicine Industrial Technology Institute) ;
  • Zengnan Mo (Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University) ;
  • Yonghua Jiang (Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University)
  • 투고 : 2025.02.15
  • 심사 : 2025.08.13
  • 발행 : 2026.03.01

초록

Background: Adrenocortical hormones, particularly 11-oxygenated androgens, are pivotal in female reproductive health and fertility. Standardized detection kits and population-specific reference intervals are lacking in China, hindering related clinical applications. Methods: A HPLC-tandem mass spectrometry (HPLC-MS/MS) pipeline was developed, rigorously validated, and applied to simultaneously quantify corticosterone, cortisone, cortisol, 18-OH cortisol, androstenedione (A4), 11β-hydroxyandrostenedione (11-OH A4), dehydroepiandrosterone, and dehydroepiandrosterone sulfate in serum samples from 455 reproductive-aged women (18-45 yrs) in Guangxi, China. Age-dependent concentration trends were analyzed, and reference intervals stratified by age (2.5th to 97.5th percentiles) were established. Correlations with body-composition metrics, ethnicity, and the menstrual cycle were investigated. Results: The HPLC-MS/MS method demonstrated high precision (intra- and inter-assay CVs <15%), accuracy, and sensitivity. All eight hormones exhibited significant age-related declines (P <0.001 for seven hormones; P =0.001 for 11-OH A4). Notably, 11-OH A4 levels were significantly lower in the 35-45-yr (3.05 nmol/L) and 25-34-yr (3.09 nmol/L) age groups than in the 18-24-yr (3.57 nmol/L) age group, whereas no significant difference was observed between the 35-45-yr and 25-34-yr age groups. Weak negative correlations were observed between the body mass index and corticosterone and cortisone levels, whereas ethnicity and the menstrual cycle showed no significant associations with hormone levels. Conclusions: We developed an HPLC-MS/MS-based method for simultaneously quantifying eight adrenocortical hormones, including 11-OH A4, and defined age-specific reference intervals for reproductive-aged Chinese women. These findings advance the clinical utility of adrenocortical hormones in diagnosing and managing reproductive disorders.

키워드

참고문헌

  1. Augsburger P, Liimatta J, Flück CE. Update on adrenarche-still a mystery. J Clin Endocrinol Metab 2024;109:1403-22. https://doi.org/10.1210/clinem/dgae008
  2. Gao X, Li F, Liu B, Wang Y, Wang Y, Zhou H. Cellular senescence in adrenocortical biology and its disorders. Cells 2021;10:3474. https://doi.org/10.3390/cells10123474
  3. Labrie F. Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues. Menopause 2019;26:220-4. https://doi.org/10.1097/GME.0000000000001177
  4. Gawlik A, Shmoish M, Hartmann MF, Malecka-Tendera E, Wudy SA, Hochberg Z. Steroid metabolomic disease signature of nonsyndromic childhood obesity. J Clin Endocrinol Metab 2016;101:4329-37. https://doi.org/10.1210/jc.2016-1754
  5. Mejorado-Molano FJ, Sanz-Calvo ML, Posada-Ayala A, Caballo-Roig N, Gavela-Pérez T, Mahillo-Fernández I, et al. Adult height in girls with idiopathic premature adrenarche: a cohort study and design of a predictive model. Front Endocrinol (Lausanne) 2022;13:852422. https://doi.org/10.3389/fendo.2022.852422
  6. Olgun EG, Cetin SK, Siklar Z, Aycan Z, Ozsu E, Ceran A, et al. Investigation of early puberty prevalence and time of addition thelarche to pubarche in girls with premature pubarche: two-year follow-up results. Clin Pediatr Endocrinol 2022;31:25-32. https://doi.org/10.1297/cpe.2021-0042
  7. Wang K, Li Y, Chen Y. Androgen excess: a hallmark of polycystic ovary syndrome. Front Endocrinol (Lausanne) 2023;14:1273542. https://doi.org/10.3389/fendo.2023.1273542
  8. O'Reilly MW, Kempegowda P, Jenkinson C, Taylor AE, Quanson JL, Storbeck KH, et al. 11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome. J Clin Endocrinol Metab 2017;102:840-8. https://doi.org/10.1210/jc.2016-3285
  9. Zhang X, Xu H, Feng G, Yang L, Zhao L, Li R, et al. Sensitive HPLC-DMS/MS/MS method coupled with dispersive magnetic solid phase extraction followed by in situ derivatization for the simultaneous determination of multiplexing androgens and 17-hydroxyprogesterone in human serum and its application to patients with polycystic ovarian syndrome. Clin Chim Acta 2023;538:221-30. https://doi.org/10.1016/j.cca.2022.11.025
  10. Adriaansen BPH, Utari A, Westra D, Juniarto AZ, Ariani MD, Ediati A, et al. 46,XX males with congenital adrenal hyperplasia: a clinical and biochemical description. Front Endocrinol (Lausanne) 2024;15:1410122.
  11. Han B, Zhu H, Yao H, Ren J, O'Day P, Wang H, et al. Differences of adrenal-derived androgens in 5-reductase deficiency versus androgen insensitivity syndrome. Clin Transl Sci 2022;15:658-66. https://doi.org/10.1111/cts.v15.3
  12. Yoshida T, Matsuzaki T, Miyado M, Saito K, Iwasa T, Matsubara Y, et al. 11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome. Endocr J 2018;65:979-90. https://doi.org/10.1507/endocrj.EJ18-0212
  13. Food and Drug Administration. Bioanalytical method validation: guidance for industry. https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf (Updated on May 2018).
  14. Define and determine the reference intervals in Clinical Laboratory, 2024. https://www.nhc.gov.cn/wjw/s9492/202407/c69784a165424889bedb36d854e61554.shtml (Updated on November 1, 2024)
  15. Kunz S, Wang X, Ferrari U, Drey M, Theodoropoulou M, Schilbach K, et al. Age- and sex-adjusted reference intervals for steroid hormones measured by liquid chromatography-tandem mass spectrometry using a widely available kit. Endocr Connect 2024;13:e230225.
  16. Bae YJ, Zeidler R, Baber R, Vogel M, Wirkner K, Loeffler M, et al. Reference intervals of nine steroid hormones over the life-span analyzed by LC-MS/MS: effect of age, gender, puberty, and oral contraceptives. J Steroid Biochem Mol Biol 2019;193:105409. https://doi.org/10.1016/j.jsbmb.2019.105409
  17. Ahn RS, Lee YJ, Choi JY, Kwon HB, Chun SI. Salivary cortisol and DHEA levels in the Korean population: age-related differences, diurnal rhythm, and correlations with serum levels. Yonsei Med J 2007;48:379-88. https://doi.org/10.3349/ymj.2007.48.3.379
  18. Nanba AT, Rege J, Ren J, Auchus RJ, Rainey WE, Turcu AF. 11-oxygenated C19 steroids do not decline with age in women. J Clin Endocrinol Metab 2019;104:2615-22. https://doi.org/10.1210/jc.2018-02527
  19. Turcu AF, Rege J, Auchus RJ, Rainey WE. 11-Oxygenated androgens in health and disease. Nat Rev Endocrinol 2020;16:284-96. https://doi.org/10.1038/s41574-020-0336-x
  20. Davio A, Woolcock H, Nanba AT, Rege J, O'Day P, Ren J, et al. Sex differences in 11-oxygenated androgen patterns across adulthood. J Clin Endocrinol Metab 2020;105:e2921-9. https://doi.org/10.1210/clinem/dgaa343
  21. Schiffer L, Kempegowda P, Sitch AJ, Adaway JE, Shaheen F, Ebbehoj A, et al. Classic and 11-oxygenated androgens in serum and saliva across adulthood: a cross-sectional study analyzing the impact of age, body mass index, and diurnal and menstrual cycle variation. Eur J Endocrinol 2023;188:lvac017.
  22. Zheng J, Wang Y, Jiang J, Jin T, Liu Y, Guo Y, et al. Decoding 11-oxygenated androgen synthesis: insights from enzyme gene expression and LC-MS/MS quantification. Eur J Endocrinol 2024;191:288-99.
  23. Paulukinas RD, Mesaros CA, and Penning TM. Conversion of classical and 11-oxygenated androgens by insulin-induced AKR1C3 in a model of human PCOS adipocytes. Endocrinology 2022;163:bqac068. https://doi.org/10.1210/endocr/bqac068
  24. Schiffer L, Oestlund I, Snoep JL, Gilligan LC, Taylor AE, Sinclair AJ, et al. Inhibition of the glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 drives concurrent 11-oxygenated androgen excess. FASEB J 2024;38:e23574. https://doi.org/10.1096/fsb2.v38.7
  25. O'Reilly MW, Kempegowda P, Walsh M, Taylor AE, Manolopoulos KN, Allwood JW, et al. AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2017;102:3327-39. https://doi.org/10.1210/jc.2017-00947
  26. Caron P, Turcotte V, Guillemette C. A quantitative analysis of total and free 11-oxygenated androgens and its application to human serum and plasma specimens using liquid-chromatography tandem mass spectrometry. J Chromatogr A 2021;1650:462228. https://doi.org/10.1016/j.chroma.2021.462228
  27. Choi MH, Kim SJ, Lew BL, Sim WY, Chung BC. Hair steroid profiling reveals racial differences in male pattern baldness between Korean and Caucasian populations. J Invest Dermatol 2013;133:822-4. https://doi.org/10.1038/jid.2012.349
  28. Lasley BL, Santoro N, Randolf JF, Gold EB, Crawford S, Weiss G, et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 2002;87:3760-7. https://doi.org/10.1210/jcem.87.8.8741
  29. Skiba MA, Bell RJ, Islam RM, Handelsman DJ, Desai R, Davis SR. Androgens during the reproductive years: what is normal for women? J Clin Endocrinol Metab 2019;104:5382-92. https://doi.org/10.1210/jc.2019-01357